Because many solid tumors, including HNSCC have hyper activated epidermal growth factor receptor (EGFR) [3],[4], there has been great interest in the use of EGFR inhibitors to control cancer growth. This evidence concerns the gene EGFR and head and neck squamous cell carcinoma.